Cite
HARVARD Citation
Serebruany, V. et al. (2015). Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevated myocardial infarction. International journal of cardiology. pp. 104-110. [Online].